Short description
Medisix Therapeutics is a provider of immune engineering company developing novel cellular therapies.
Description
Medisix Therapeutics is a Singapore-based immune engineering company developing novel cellular therapies to address T cell malignancies. Their technology platform originates from world expert in translational immunology, Professor Dario Campana, MD, PhD, a physician scientist who pioneered chimeric antigen receptor T cell (CAR-T) biology. Their programs utilize proprietary immune engineering approaches that enable T cell leukemias and lymphomas to be targeted with cell therapy.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Singapore, Central Region, Singapore, Asia
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh, Uh Ohhhh, Noaccess
Sign in for full access
Founders
Dario Campana